Wells Fargo
ZLAB icon

Wells Fargo’s Zai Lab ZLAB Stock Holding History

Wells Fargo’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Sell
60
-5,362
-99% -$106K ﹤0.01% 6441
2026
Q1 		$102K Sell
5,422
-87,718
-94% -$1.63M ﹤0.01% 5098
2025
Q4 		$1.64M Sell
93,140
-81,992
-47% -$1.92M ﹤0.01% 3605
2025
Q3 		$5.94M Buy
175,132
+652
+0.4% +$22.4K ﹤0.01% 2429
2025
Q2 		$6.1M Buy
174,480
+35,650
+26% +$1.17M ﹤0.01% 2313
2025
Q1 		$5.02M Buy
138,830
+97,876
+239% +$3.01M ﹤0.01% 2411
2024
Q4 		$1.07M Buy
40,954
+40,454
+8,091% +$1.12M ﹤0.01% 3661
2024
Q3 		$12.1K Hold
500
– – ﹤0.01% 5752
2024
Q2 		$8.66K Hold
500
– – ﹤0.01% 5781
2024
Q1 		$8.01K Buy
+500
New +$10.5K ﹤0.01% 5810
2023
Q4 		– Sell
-141
Closed -$3.43K – 7727
2023
Q3 		$3.43K Buy
+141
New +$3.75K ﹤0.01% 6011
2023
Q2 		– Sell
-23
Closed -$765 – 7720
2023
Q1 		$765 Buy
+23
New +$882 ﹤0.01% 6449
2022
Q4 		– Sell
-1,000
Closed -$34K – 7776
2022
Q3 		$34K Sell
1,000
-822
-45% -$35.2K ﹤0.01% 5132
2022
Q2 		$64K Buy
1,822
+33
+2% +$1.16K ﹤0.01% 4909
2022
Q1 		$79K Sell
1,789
-47
-3% -$2.27K ﹤0.01% 5436
2021
Q4 		$116K Sell
1,836
-301,841
-99% -$25.6M ﹤0.01% 5558
2021
Q3 		$32M Sell
303,677
-274,414
-47% -$39.4M 0.01% 1334
2021
Q2 		$102M Buy
578,091
+13,309
+2% +$2.14M 0.02% 666
2021
Q1 		$75.4M Buy
564,782
+12,508
+2% +$1.94M 0.02% 829
2020
Q4 		$74.7M Buy
552,274
+11,838
+2% +$1.21M 0.02% 776
2020
Q3 		$44.9M Buy
540,436
+94,021
+21% +$7.55M 0.01% 928
2020
Q2 		$36.7M Sell
446,415
-127,628
-22% -$8.63M 0.01% 1018
2020
Q1 		$29.6M Sell
574,043
-49,820
-8% -$2.6M 0.01% 1031
2019
Q4 		$25.9M Sell
623,863
-15,176
-2% -$560K 0.01% 1309
2019
Q3 		$20.7M Sell
639,039
-125,357
-16% -$4.3M 0.01% 1418
2019
Q2 		$26.7M Buy
764,396
+298,850
+64% +$8.8M 0.01% 1288
2019
Q1 		$13.7M Buy
465,546
+453,346
+3,716% +$12.4M ﹤0.01% 1713
2018
Q4 		$283K Buy
+12,200
New +$226K ﹤0.01% 4706

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo's ZLAB Position: Q2 2026 in Review

Wells Fargo reduced its Zai Lab (ZLAB) stake by 99% in Q2 2026, selling an estimated $106K and leaving 60 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #6441.

Wells Fargo first reported a position in ZLAB in Q4 2018 and has held it in 28 quarters since. The position peaked at $102M in Q2 2021. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Wells Fargo held 60 shares of Zai Lab worth $1.14K as of Q2 2026.
  • Wells Fargo sold 5,362 Zai Lab shares in Q2 2026, an estimated $106K.
  • Zai Lab made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6441 holding.
  • Wells Fargo first reported a position in Zai Lab in Q4 2018 and has held it in 28 quarters since.
  • Wells Fargo's Zai Lab position peaked at $102M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.